13 years of clinical peptide experience, physician oversight, comprehensive lab monitoring, and personalized protocols not generic cookie-cutter stacks
Altme, S., Laanpere, M., Campoy, C
Exosomes derived from eutopic and ectopic endometrial cells in endometriosis patients exhibit altered profiles of miRNAs (miR-22-3p, miR-320a, miR-17, miR-106a), lncRNAs (LINC00998, NEAT1, PVT1), and circRNAs
Blood levels rise across the first several weekly doses and settle near steady state after about four weeks. That is why the four-week hold matters: the full effect of a dose change is not visible in the first few days
The results were striking
Below is a comprehensive comparison